While traders slog through yet another earnings season, former trader Raj Mahal muses about what he DOESN'T miss about life on the Street.» Read More
The GoodHaven Fund is up more than four percent. Discussing whether now is the time for investors to jump in, with Keith Trauner, GoodHaven Capital portfolio manager.
Discussing whether the deal between Express Scripts and Medco will give a real leg up in pricing and competition, with Les Funtleyder, Miller Tabak portfolio manager.
A look ahead of Microsoft earnings, with Brent Thill, UBS director/software analyst; and the Fast Money traders share their midday trades in Pops & Drops.
It's a busy day in Europe - and a complicated one for investors.
Discussing the reasoning behind his downgrade of Intel, with Romit Shah, Nomura Securities.
The outlook for the M&A front and details on the current hot deals in the making, with Blair Effron, Centerview Partners co-founder.
This is the first paragraph/short story.
Stocks rallied across the board Thursday after some positive economic news, a draft document showing plans for a wide-ranging response to the euro zone debt crisis, in addition to a handful of positive earnings news.
The stock market continues to be very sensitive to headlines on EU and U.S. debt talks this week. The Dow is up over 140 points as of this writing and is just shy of this month’s highs. The blue chip index is now just less than 100 points below its 3-year high set back at the end of April.
Express Script’s deal to acquire Medco Health Solutions for roughly $29 billion in cash and stock is being applauded by ESRX shareholders, but the key constituency on whether this deal will happen is likely to be the Federal Trade Commission.
Insight on whether now is the time to invest in telecom stocks, with Frank Louthan, Raymond James, and Christopher Larsen, Piper Jaffray & Co.
Insight on what the huge deal in the healthcare sector will mean for the industry going forward, with Eugene Goldenberg,BB&T Capital Markets.
Advice for investors to protect and profit from investments during earnings season, with Andy Bischel, SKBA Capital Management and Joseph Duran, United Capital Financial Partners.
Here's why you should keep a close eye on these six stocks.
A look at what the deal between Express Scripts and Medco Health means for the already changing healthcare industry, with Steven Halper, Stifel Nicolaus managing director.
Weighing in on the pricing behind the energy company's IPO, with Frederick Henderson, SunCoke Energy CEO.
CNBC's Kate Kelly has the details on Morgan Stanley's Q2 earnings, labeling it as an important milestone. Morgan Stanley earned $9.3 billion in net revenues, a 17 percent rise from the same period last year.
Mad Money host Jim Cramer shares his stocks to watch before the opening bell.
Futures rallied Thursday after a new bailout fund document stated it will extend loans to ease the euro zone debt crisis and as investors largely shrugged off a disappointing jobless claims news.